Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-234502
Filing Date
2012-05-15
Accepted
2012-05-15 16:07:01
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d328243d10q.htm 10-Q 350226
2 SECTION 302 CEO CERTIFICATION d328243dex311.htm EX-31.1 6410
3 SECTION 302 CFO CERTIFICATION d328243dex312.htm EX-31.2 6218
4 SECTION 906 CEO AND CFO CERTIFICATION d328243dex321.htm EX-32.1 4286
  Complete submission text file 0001193125-12-234502.txt   1556861

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cik0001429260-20120331.xml EX-101.INS 152462
6 XBRL TAXONOMY EXTENSION SCHEMA cik0001429260-20120331.xsd EX-101.SCH 13610
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cik0001429260-20120331_cal.xml EX-101.CAL 31196
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cik0001429260-20120331_def.xml EX-101.DEF 33778
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cik0001429260-20120331_lab.xml EX-101.LAB 116257
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cik0001429260-20120331_pre.xml EX-101.PRE 74819
Mailing Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01802
Business Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01802 781-238-6621
CORONADO BIOSCIENCES INC (Filer) CIK: 0001429260 (see all company filings)

EIN.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35366 | Film No.: 12844625
SIC: 2834 Pharmaceutical Preparations